Age‐related increase in plasma p‐tau217 in amyloid‐beta–negative cognitively unimpaired individuals affects diagnostic interpretation
Alzheimer's & Dementia · 2026-06 · 22 (6)
DOI: 10.1002/alz.71532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.06.2026. Verfasst von Anna E Mammel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neurocode USA Inc, Bellingham, Washington, USA. Hauptthemen laut MEDLINE: Aging, Amyloid beta-Peptides, tau Proteins. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION The extent to which non‐pathological aging influences plasma biomarkers remains unclear. Here, we investigate factors influencing plasma p‐tau217 levels in cognitively unimpaired (CU), amyloid‐beta–negative (Aβ‐) individuals. METHODS Plasma p‐tau217 was measured in CU Aβ‐ positron emission tomography–negative (PET‐) participants using two immunoassays (ALZpath n = 360 and LUMIPULSE G1200 n = 73). Associations between p‐tau217 and age groups (60–69, 70–79, and 80+ years), apolipoprotein E ( APOE) genotype, and gender were evaluated. RESULTS ALZpath plasma p‐tau217 showed a non‐pathological age‐related increase ( p < 0.001), and increased percentage within the intermediate zone with age. Lumipulse p‐tau217 showed an increase in the percentage of subjects with positive results with age, however, this trend was not significant ( p > 0.05). Men had higher levels of p‐tau217 only with the ALZpath assay ( p = 0.02; Lumipulse: p = 0.81). No significant associations were found between p‐tau217 and APOE genotype. DISCUSSION Our results highlight the importance of incorporating age and sex into the interpretation of plasma p‐tau217 particularly in preclinical stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurocode USA Inc, Bellingham, Washington, USA.
- University of Gothenburg, Gothenburg, Sweden.
- BC Neuroimmunology Laboratory, Vancouver, British Columbia, Canada.
- Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- The Florey Institute of Neuroscience and Mental Health, the University of Melbourne, Parkville, Victoria, Australia.
- The Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Brisbane, Queensland, Australia.
Zitieren
APA
Mammel, A. E., Gonzalez-Ortiz, F., Mousavi, A., Hallett, K., Encarnacion, M., Biehl, D., Gill, P., Ismael, S., Fowler, C., Doecke, J. D., Ward, L., & Frykman, H. (2026). Age‐related increase in plasma p‐tau217 in amyloid‐beta–negative cognitively unimpaired individuals affects diagnostic interpretation. Alzheimer's & Dementia, 22(6). https://doi.org/10.1002/alz.71532
Vancouver
Mammel AE, Gonzalez-Ortiz F, Mousavi A, Hallett K, Encarnacion M, Biehl D, et al. Age‐related increase in plasma p‐tau217 in amyloid‐beta–negative cognitively unimpaired individuals affects diagnostic interpretation. Alzheimer's & Dementia. 2026;22(6). doi:10.1002/alz.71532
BibTeX
@article{Mammel2026,
author = {Mammel, Anna E and Gonzalez-Ortiz, Fernando and Mousavi, Ali and Hallett, Kelsey and Encarnacion, Mary and Biehl, Don and Gill, Pradip and Ismael, Sazan and Fowler, Christopher and Doecke, James D and Ward, Larry and Frykman, Hans},
title = {Age‐related increase in plasma p‐tau217 in amyloid‐beta–negative cognitively unimpaired individuals affects diagnostic interpretation},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {6},
doi = {10.1002/alz.71532}
}
EUVIMED